Drugmaker Schering-Plough yesterday reported a slight rise in third-quarter earnings as quality control problems at its US plants continue to disrupt production of respiratory and other drugs. The US firm, which employs about 1,000 people in Cork and Wicklow, said it earned $601 million, or 41 US cents per share, compared with $591 million, or 40 US cents per share, a year earlier and in line with analyst forecasts.
Earnings rise at Schering-Plough
Drugmaker Schering-Plough yesterday reported a slight rise in third-quarter earnings as quality control problems at its US plants…
From maternity leave to remote working: Submit your work-related questions here
Listen to Inside Business podcast for a look at business and economics from an Irish perspective
Sign up to the Business Today newsletter for the latest new and commentary in your inbox









